AbbVie · 2 days ago
Financial Analyst
Worcester, MA
Full-time
Onsite
Entry Level
$64K/yr - $122K/yr
2+ years expAbbVie is a company dedicated to delivering innovative medicines and solutions that address serious health issues. They are seeking a Financial Analyst to prepare and analyze financials while supporting the S&T Biologics and IME business, ensuring compliance and accuracy in financial reporting.
BiotechnologyFinancial ServicesHealth CareMedicalPharmaceuticalVenture Capital
Responsibilities
Prepare monthly journal entries to ensure balance sheet accuracy
Prepare monthly balance sheet reconciliations
Ensure monthly accounts comply with all policies and procedures including Sarbanes – Oxley requirements
Support ABC Core Services, manage ~$30MM Site Facility/Core budget. Work with FP&A manager on allocations
Responsible for Monthly close of core this would include variance analysis, and Last Best Estimate (LBE) submission
Work with S&T Financial Analyst on tracking OT for contractors
GR/IR analysis and maintenance which includes working with team to keep items below the 90 days and scheduling meetings for status updates
Prepare Miscellaneous accrual for balance sheet review
Work with manager on Annual tax packages and miscellaneous tax requests
Qualification
Required
Bachelor's Degree in Accounting, Finance, Economics or equivalent degree
Knowledge on Pharmaceutical R&D, Operations and AbbVie pipeline in general
Minimum 2 years related experience
Benefits
Paid time off (vacation, holidays, sick)
Medical/dental/vision insurance
401(k)
Company
AbbVie
AbbVie is a biopharmaceutical company focused on immunology, oncology, neuroscience, virology, and aesthetics. It is a sub-organization of AbbVie.
10001+ employees
H1B Sponsorship
AbbVie has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (273)
2024 (190)
2023 (225)
2022 (284)
2021 (186)
2020 (186)
Funding
Current Stage
Public CompanyTotal Funding
$15B2024-02-27Post Ipo Debt· $15B
2023-03-08Post Ipo Equity· $0.25M
2012-12-20IPO
Leadership Team
Robert Michael
Chairman of the Board and Chief Executive Officer
Micah Bregman
Vice President, Global Strategy and Pipeline, Allergan Aesthetics
Recent News
2026-01-09
2026-01-09
Company data provided by crunchbase